Background: Previous guidelines for the management of thyroid nodules and cancers were
geared toward adults. Compared with thyroid neoplasms in adults, however, those in the …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …

Abstract Context: Thyroglobulin autoantibodies (TgAb) are primarily measured in serum in
conjunction with thyroglobulin (Tg)—the primary tumor marker used to monitor patients with …

Thyroid nodules are approximately 4 times more common in women than in men. Palpable
nodules increase in frequency throughout life, reaching a prevalence of approximately 5% in …

Objective Thyroglobulin measurement is the cornerstone of modern management of
differentiated thyroid cancer, with clinical decisions on treatment and follow-up based on the …

Context: Changes in thyroglobulin (Tg) and/or Tg antibody (TgAb) methods can disrupt the
serial monitoring of differentiated thyroid carcinoma (DTC) patients. Objective: This study …

Thyroglobulin autoantibodies (TgAb) are detected at diagnosis or during treatment in
approximately 25% of patients with differentiated thyroid cancer (DTC). When present, TgAb …

Background: Even though the presence of antithyroglobulin antibodies (TgAbs) represents a
significant problem in the follow-up of patients with differentiated thyroid cancer (DTC), the …